                                                        SPARR CONV.HOSP.
                                                     2367 WEST PICO BLVD.
                                                     L.A.CA. 90006
 
 
 
         PROTOTYPE PSYCHO TROPIC DRUG POLICY:
 
 
 
        1.POLICY
          ALL PATIENTS RECEIVING ROUTINE AND "AS NEEDED" MEDICATION(S)
          PRESCRIBED FOR CONTROL OF A SPECIFIC BEHAVIOR OR MANIFESTATION OF A
          DISORDERED THOUGHT PROCESS SHALL BE MONITORED FOR EFFECTIVENESS AND
          SIDE EFFECTS. THERAPEUTIC AND TOXIC DATA WILL BE REPORTED TO THE
          PHYSICIAN.
 
        2.PROCEDURE
          1. THE PATIENT'S PLAN OF CARE SHALL INCLUDE THE SPECIFIC BEHAVIOR(S)
          FOR WHICH THE MEDICATION IS BEING USED, THE GOAL OF THERAPY, AND
          REVIEW DATE SIDE EFFECTS OF THE MEDICATION.
          2. THE STAFF SHALL MONITOR AND RECORD THE OCCURRENCES OF BEHAVIOR
          BEHAVIOR IN THE HEALTH RECORD.
          3. THE STAFF SHALL OBSERVE AND DOCUMENT THE OCCURRENCES OF MEDICATION
          SIDE EFFECTS IN THE HEALTH RECORD.
          4. THE STAFF SHALL MONTHLY SUMMARIZE THE INCIDENCE OF BEHAVIOR
          EPISODES AND SIDE EFFECTS IN THE HEALTH RECORD FOR THE PRESCRIBER.
 
 
 
 
 
          INTENT:
 
          THAT A PSYCHO TROPIC POLICY BE INCORPORATED INTO THE FACILITY'S
          NURSING MANUAL; IT IS IMPERATIVE THAT   AN
          INDIVIDUALIZED PSYCHO TROPIC POLICY   EXIST THAT MEETS OUR NEEDS.
          SPECIFICALLY #2,#3, AND #4 IN THE ABOVE PROCEDURE MUST DESCRIBE
          WHERE IN THE HEALTH RECORD EACH ITEM IS TO BE DOCUMENTED FOR THAT
          FACILITY. ONLY THE WILL THE POLICY BE COMPLETE.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 PAGE 2
 
 
                           PSYCHO TROPIC DRUG POLICY
 
 
         I. POLICY
 
            ALL PATIENT RECEIVING ROUTINE AND "AS NEEDED"
            MEDICATION(S) PRESCRIBED FOR CONTROL OF A SPECIFIC
            BEHAVIOR OR MANIFESTATION  OF A DISORDERED THOUGHT
            PROCESS  SHALL BE MONITORED FOR EFFECTIVENESS AND
            SIDE EFFECTS. THERAPEUTIC AND TOXIC DATA WILL BE
            REPORTED TO THE PHYSICIAN.
 
 
       II.  PROCEDURE
 
            1. THE PATIENT'S PLAN OF CARE SHALL INCLUDE THE SPECIFIC
               BEHAVIOR(S) FOR WHICH THE MEDICATION IS BEING USED, THE
               GOAL OF THERAPY, AND COMMON SIDE EFFECTS OF THE MEDICATION.
 
            2. THE STAFF SHALL MONITOR AND RECORD THE OCCURRENCES OF
               BEHAVIOR BEHAVIOR ON THE MEDICATION SHEET.
 
            3. THE STAFF SHALL OBSERVE AND DOCUMENT THE OCCURRENCES OF
               MEDICATION SIDE EFFECTS IN NURSES NOTES.
 
            4. THE STAFF SHALL MONTHLY SUMMARIZE THE INCIDENCE OF
               BEHAVIOR EPISODES AND SIDE EFFECTS ON THE BEHAVIOR
               SUMMARY SHEET ON THE PHYSICIANS ORDERS SECTION IN THE  PT CHART.
 
 
             ********SEE PSYCHO TROPIC DRUG INDEX ***************
 
                               ANTIDEPRESSANT MEDICATION
               ANI ANXIETY MEDICATION        ANTI PSYCHOTIC MEDICATION
 